HEMANGIOBLASTOMA
Clinical trials for HEMANGIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEMANGIOBLASTOMA trials appear
Sign up with your email to follow new studies for HEMANGIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New brain scan could spot tumors missed by standard MRI
Diagnosis Recruiting nowThis study tests whether a special PET/MRI scan using a radioactive tracer called Ga68-DOTATATE can better detect certain brain tumors (like meningioma) and tell them apart from changes caused by past treatments. About 200 adults with these tumors will get the scan alongside stan…
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New brain tumor labels could guide better treatments
Knowledge-focused Recruiting nowThis study is collecting data from 1,650 people with various brain tumors to see if the updated 2021 WHO classification system helps doctors group patients more accurately and choose better treatments. Researchers will track responses to therapy, survival, and tumor features over…
Matched conditions: HEMANGIOBLASTOMA
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC